EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/04/2025
Back to search
Official data from USPTO
ENTOS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
01/08/2025
Trademark type
Word
Nice classes
42
Filing date
08/20/2021
Registration date
08/29/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/29/2023
Last transaction
01/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/03/2013
First use in commerce
10/03/2013
Drawing code
4
Owner type
03
Owner location
EDMONTON, AB, CA
Examiner
MCMORROW, JANICE
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ENTOS PHARMACEUTICALS INC.
Entos, Inc.
Representatives
Theodore R. Remaklus Thompson Hine LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
research and development in the field of computational biologybioinformaticsgenomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceuticalmedicalscientificbiotechnologybiopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development of pharmaceutical preparations and substances for use in clinical trials; scientific and technological servicesresearch and design in the field of computational chemistrymachine learning and artificial intelligence for use in chemistrybiologyphysicsbiochemistrychemical engineeringcomputer sciencedesign and optimization of moleculesmaterialsdrugs; chemistry serviceslaboratory research in the fields of chemistry and design of new chemistry; chemistry services in the nature of drugmolecular discovery servicesproduct development services; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drugmaterialsmolecular development; technical data analysis services being technology advisory services relating to computer programs for use in chemistrybiologyphysicsbiochemistrychemical engineeringcomputer sciencethe discovery of new moleculesmaterialsdrugsmachine learning techniques; computer programming in the fields of molecularmaterialsdrug development; computer consultancy services being computer software consultation in the field of drugmaterialsmolecular development; computer software consultation servicesassistance and consulting in connection with the development of computer applicationsdatabases and systems for use in the field of drugmaterialsmolecular development; consulting services in the design and implementation of computer-based information systems for businessprovision of online information relating to computer hardware and software design in the field of drugmaterialsmolecular development; creationmaintenancehostingdesign of websites in the field of drugmaterialsmolecular development; provision of online non-downloadable software for simulations for drugmaterialsmolecular discovery; software as a service (saas) services featuring computer software platforms for use in optimizing drugmaterialsmolecular discovery; platform as a service (paas) featuring computer software platforms for use in optimizing drugmaterialsmolecular discovery; creating website based indexes of information for others using information technology for use in the field of drugmaterialsmolecular development; computer graphics design servicesrealization of computer graphics and digital imaging for use in the field of drugmaterialsmolecular development; scientific research in connection with computerized automation of technical processes for use in the field of drugmaterialsmolecular development; cloud-based computing featuring software for optimizing the development of new molecules and designing and discovering moleculesdrugsbattery materialsother molecular products
Publications
History of USPTO decisions and trademark events.
41 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/04/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/04/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/04/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/04/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/04/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/01/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/01/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/01/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/01/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/01/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/01/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/01/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/30/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/29/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/29/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/27/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/26/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/25/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/24/2023
IUAF
USE AMENDMENT FILED
06/30/2023
EISU
TEAS STATEMENT OF USE RECEIVED
06/30/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/13/2023
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
05/04/2023
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
10/27/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/25/2022
PUBO
PUBLISHED FOR OPPOSITION
10/25/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/05/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/20/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/17/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/16/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/16/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/23/2022
GNRT
NON-FINAL ACTION E-MAILED
05/23/2022
CNRT
NON-FINAL ACTION WRITTEN
05/23/2022
DOCK
ASSIGNED TO EXAMINER
05/23/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/07/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/08/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/08/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/08/2021
NWAP
NEW APPLICATION ENTERED
08/24/2021
Continuous trademark protection
Get notified about every new filing that threatens ENTOS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.